Literature DB >> 12571631

Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.

W H van der Laan1, P H A Quax, C A Seemayer, L G M Huisman, E J Pieterman, J M Grimbergen, J H Verheijen, F C Breedveld, R E Gay, S Gay, T W J Huizinga, T Pap.   

Abstract

Matrix metalloproteinases (MMPs) are believed to be pivotal enzymes in the invasion of articular cartilage by synovial tissue in rheumatoid arthritis (RA). Here, we investigated the effects of gene transfer of tissue inhibitors of metalloproteinases (TIMPs) on the invasiveness of RA synovial fibroblasts (RASF) in vitro and in vivo. Adenoviral vectors (Ad) were used for gene transfer. The effects of AdTIMP-1 and AdTIMP-3 gene transfer on matrix invasion were investigated in vitro in a transwell system. Cartilage invasion in vivo was studied in the SCID mouse co-implantation model for 60 days. In addition, the effects of AdTIMP-1 and AdTIMP-3 on cell proliferation were investigated. A significant reduction in invasiveness was demonstrated in vitro as well as in vivo in both the AdTIMP-1- and AdTIMP-3-transduced RASF compared with untransduced SF or SF that were transduced with control vectors. in vitro, the number of invading cells was reduced to 25% (P<0.001) in the AdTIMP-1-transduced cells and to 13% (P<0.0001) in the AdTIMP-3-transduced cells (% of untransduced cells). Cell proliferation was significantly inhibited by AdTIMP-3 and, less, by AdTIMP-1. In conclusion, overexpression of TIMP-1 and TIMP-3 by Ad gene transfer results in a marked reduction of the invasiveness of RASF in vitro and in the SCID mouse model. Apart from the inhibition of MMPs, a reduction in proliferation rate may contribute to this effect. These results suggest that overexpression of TIMPs, particularly TIMP-3 at the invasive front of pannus tissue, may provide a novel therapeutic strategy for inhibiting joint destruction in RA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12571631     DOI: 10.1038/sj.gt.3301871

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  30 in total

Review 1.  A question of transformation: the synovial fibroblast in rheumatoid arthritis.

Authors:  Laurie S Davis
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 2.  Metalloproteinases, inflammation, and rheumatoid arthritis.

Authors:  F F Mohammed; D S Smookler; R Khokha
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 3.  Gene targeting: roadmap to future therapies.

Authors:  Lars C Huber; Thomas Pap; Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

4.  Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Authors:  Lennart Holterman; Ronald Vogels; Remko van der Vlugt; Martijn Sieuwerts; Jos Grimbergen; Jorn Kaspers; Eric Geelen; Esmeralda van der Helm; Angelique Lemckert; Gert Gillissen; Sandra Verhaagh; Jerome Custers; David Zuijdgeest; Ben Berkhout; Margreet Bakker; Paul Quax; Jaap Goudsmit; Menzo Havenga
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 5.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 6.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 7.  Gene therapy works in animal models of rheumatoid arthritis...so what!

Authors:  Fons A J van de Loo; Jeroen Geurts; Wim B van den Berg
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 8.  Are fibroblasts involved in joint destruction?

Authors:  T Pap; I Meinecke; U Müller-Ladner; S Gay
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

Review 9.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

10.  Impact of sex, age, body mass index and handedness on finger joint space width in patients with prolonged rheumatoid arthritis using computer-aided joint space analysis.

Authors:  Alexander Pfeil; Andreas Hansch; Gabriele Lehmann; Thorsten Eidner; Max L Schäfer; Peter Oelzner; Diane M Renz; Gunter Wolf; Gert Hein; Werner A Kaiser; Joachim Böttcher
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.